Treatment for those who have taken a lot of HIV drugs in the past

The goal of HIV treatment is an undetectable viral load – and this is usually possible, even if you have taken a lot of anti-HIV drugs in the past and have virus that is drug-resistant.

If you need to change HIV treatment because your viral load has become detectable, it is very important that you have a resistance test. The results of this test will enable your doctor find the anti-HIV drugs that have the best chance of working for you.

Important treatment options for people who have HIV with resistance include the ritonavir-boosted protease inhibitor darunavir (Prezista), the NNRTI etravirine (Intelence), the integrase inhibitors raltegravir (Isentress) and elvitegravir, the CCR5 or entry inhibitor maraviroc (Celsentri) and the fusion inhibitor T-20 (enfuvirtide, Fuzeon).

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap